Core Binding Factor Acute Myeloid Leukemia
5 clinical trials · Condition
◉ Watch Core Binding Factor Acute Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| Avapritinib in CBF-AML With KIT Mutations (NCT05821738) | The First Affiliated Hospital of Soochow University | 2022-06-01 |
| Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML (NCT05404516) | Nanfang Hospital, Southern Medical University | 2020-01-01 |
| Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT01238211) | National Cancer Institute (NCI) | 2010-12-14 |
Track Core Binding Factor Acute Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.